
The Economics of Weight Loss Drugs, Thinness, and Class Signaling
The Money with Katie Show
Evolution of GLP-1 Medications
This chapter explores the development and influence of GLP-1 medications like Ozempic and Wegovi in diabetes and weight management. It discusses the historical context, market dynamics, and the role of major pharmaceutical companies, particularly focusing on Novo Nordisk and Eli Lilly. Additionally, it examines societal perceptions of obesity medications, including their benefits, health risks, and the cultural stigma surrounding weight loss interventions.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.